article thumbnail

How Banks and Credit Unions Are Getting Serious About Culture Change and Employee Engagement

Integrity Solutions

While focusing on culture is a step in the right direction, changing the culture isn’t as simple as putting people through a training program. Why Isn’t Training Enough To Drive Culture Change? The problem is that many organizations view the training itself as a catalyst for culture change.

Training 200
article thumbnail

How to Thrive in the U.S. Medical Device Market With Stéphane Toupin

Evolve Your Success

Seventeen years in the pharmaceutical industry as a sales representative, sales manager, government affairs, market access, and training. Started a medical device distribution in 2012, covering all of Canada. Bachelor’s degree in medical biology and Master’s in Experimental Medicine. Moved down to the USA in 2015.

Medical 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

PM360 Presents the 2024 Innovators

PM360

Established in 2012, PM360 introduced the first-ever issue focused entirely on our industrys latest innovations. Categories explore every sector of the healthcare industry, from life sciences to marketing. PM360 would like to welcome you to the new age of innovation with our illuminating Innovations Issue.

Marketing 100
article thumbnail

Healthcare Systems Today And The Role Of Social Media Within It With Dr. Alejandro Badia

Evolve Your Success

Learn how a childhood experience with his grandmother’s rheumatoid arthritis ignited his passion for hand surgery, leading to his extensive training at N.Y.U. where he also trained in orthopedics. Badia’s journey from his immigrant roots to becoming a leading medical practitioner in Miami is truly inspiring. F.R.C.S.I.,

Media 130
article thumbnail

MHRA Chief Executive to step down

European Pharmaceutical Review

Her educational background includes training in medicine in Oxford after completing a master’s degree by research in Pharmacology. In 2012, Dame June was elected as the first chair of the European Pharmacovigilance Risk Assessment Committee, MHRA added.

Safety 111
article thumbnail

How can evidence-based medicine (EBM) methodology support drug withdrawals?

European Pharmaceutical Review

Our research looked at products that were voluntarily withdrawn, or had their licence revoked or suspended within the EU for a safety reason between 2012 and 2016. The Human Medicines Regulations 2012, UK statutory instruments, 2012 No 1916, PART 5, Revocation, variation and suspension of marketing authorisation. Study focus.

article thumbnail

Understanding the evidence used in drug product withdrawals

European Pharmaceutical Review

Between 1999 and 2001, it supported 17 percent of withdrawals, between 2002 and 2011, it supported 26 percent of withdrawals and by 2012 to 2016, 80 percent of withdrawals were supported by observational studies (cohort, case-control, or other epidemiologic design). Meta-analyses contributed least frequently (31.4 Lane S, Lynn E, Shakir S.

Medicine 116